COVID-19: dealing with a potential risk factor for chronic neurological disorders
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
COVID-19: dealing with a potential risk factor for chronic neurological disorders
Authors
Keywords
-
Journal
JOURNAL OF NEUROLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-08-27
DOI
10.1007/s00415-020-10131-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Young onset and late onset Parkinson’s disease exhibit a different profile of fluid biomarkers and clinical features.
- (2020) Tommaso Schirinzi et al. NEUROBIOLOGY OF AGING
- T Helper Cells: The Modulators of Inflammation in Multiple Sclerosis
- (2020) Martina Kunkl et al. Cells
- SARS-CoV-2 can induce brain and spine demyelinating lesions
- (2020) Luca Zanin et al. ACTA NEUROCHIRURGICA
- Inflammation in Neurological Disorders: The Thin Boundary Between Brain and Periphery
- (2020) Carlo Cervellati et al. ANTIOXIDANTS & REDOX SIGNALING
- Subjective neurological symptoms frequently occur in patients with SARS-CoV2 infection
- (2020) Claudio Liguori et al. BRAIN BEHAVIOR AND IMMUNITY
- Nervous system involvement after infection with COVID-19 and other coronaviruses
- (2020) Yeshun Wu et al. BRAIN BEHAVIOR AND IMMUNITY
- Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis
- (2020) Brandon Michael Henry et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- SARS‐CoV‐2, the Virus that Causes COVID‐19: Cytometry and the New Challenge for Global Health
- (2020) Andrea Cossarizza et al. CYTOMETRY PART A
- Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study
- (2020) Jerome R. Lechien et al. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY
- Does SARS‐Cov‐2 invade the brain? Translational lessons from animal models
- (2020) S. Natoli et al. EUROPEAN JOURNAL OF NEUROLOGY
- Prevalence of narcolepsy, other sleep disorders, and diagnostic tests from 2013–2016: insured patients actively seeking care
- (2020) John Acquavella et al. Journal of Clinical Sleep Medicine
- Guillain‐Barr é syndrome during SARS‐CoV ‐2 pandemic: A case report and review of recent literature
- (2020) Erika Scheidl et al. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
- SARS‐CoV ‐2: At the Crossroad Between Aging and Neurodegeneration
- (2020) Alice Lippi et al. MOVEMENT DISORDERS
- Infection of bat and human intestinal organoids by SARS-CoV-2
- (2020) Jie Zhou et al. NATURE MEDICINE
- Self-reported needs of patients with Parkinson’s disease during COVID-19 emergency in Italy
- (2020) Tommaso Schirinzi et al. NEUROLOGICAL SCIENCES
- Ischemic injury precipitates neuronal vulnerability in Parkinson's disease: Insights from PINK1 mouse model study and clinical retrospective data
- (2020) Paola Imbriani et al. PARKINSONISM & RELATED DISORDERS
- Disruption of cellular proteostasis by H1N1 influenza A virus causes α-synuclein aggregation
- (2020) Rita Marreiros et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019
- (2020) Adeel S. Zubair et al. JAMA Neurology
- Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China
- (2020) Ling Mao et al. JAMA Neurology
- B and T Cells Driving Multiple Sclerosis: Identity, Mechanisms and Potential Triggers
- (2020) Jamie van Langelaar et al. Frontiers in Immunology
- Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients
- (2020) Jing Liu et al. EBioMedicine
- Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis
- (2020) Ren Mao et al. Lancet Gastroenterology & Hepatology
- Cytokines in narcolepsy: A systematic review and meta-analysis
- (2020) Soheil Mohammadi et al. CYTOKINE
- The pathogenesis and treatment of the `Cytokine Storm' in COVID-19
- (2020) Qing Ye et al. JOURNAL OF INFECTION
- An Italian programme for COVID-19 infection in multiple sclerosis
- (2020) Maria Pia Sormani LANCET NEUROLOGY
- Gut microbiota and Covid-19- possible link and implications
- (2020) Debojyoti Dhar et al. VIRUS RESEARCH
- Clinical Characteristics and Outcomes in Patients With Coronavirus Disease 2019 and Multiple Sclerosis
- (2020) Céline Louapre et al. JAMA Neurology
- Impact of infection on risk of Parkinson’s disease: a quantitative assessment of case-control and cohort studies
- (2019) Lei Meng et al. JOURNAL OF NEUROVIROLOGY
- Dietary Vitamin E as a Protective Factor for Parkinson's Disease: Clinical and Experimental Evidence
- (2019) Tommaso Schirinzi et al. Frontiers in Neurology
- CD8+ T cells from patients with narcolepsy and healthy controls recognize hypocretin neuron-specific antigens
- (2019) Natasja Wulff Pedersen et al. Nature Communications
- Association between pathological and MRI findings in multiple sclerosis
- (2019) Massimo Filippi et al. LANCET NEUROLOGY
- Association between physical activity and dementia’s risk factors in patients with Parkinson’s disease
- (2019) Mohammad Alwardat et al. JOURNAL OF NEURAL TRANSMISSION
- Influenza M2 protein regulates MAVS-mediated signaling pathway through interacting with MAVS and increasing ROS production
- (2019) Ruifang Wang et al. Autophagy
- The olfactory bulb: A link between environmental agents and narcolepsy
- (2019) Isamu Mori MEDICAL HYPOTHESES
- C-Reactive Protein and Risk of Parkinson's Disease: A Systematic Review and Meta-Analysis
- (2019) Xiaohui Qiu et al. Frontiers in Neurology
- Mitochondrial Reactive Oxygen Species Contribute to Pathological Inflammation During Influenza A Virus Infection in Mice
- (2019) Eunice E. To et al. ANTIOXIDANTS & REDOX SIGNALING
- Intestinal infection triggers Parkinson’s disease-like symptoms in Pink1−/− mice
- (2019) Diana Matheoud et al. NATURE
- Narcolepsy — clinical spectrum, aetiopathophysiology, diagnosis and treatment
- (2019) Claudio L. A. Bassetti et al. Nature Reviews Neurology
- The Contribution of Gut Barrier Changes to Multiple Sclerosis Pathophysiology
- (2019) Maria Chiara Buscarinu et al. Frontiers in Immunology
- Systemic activation of Nrf2 pathway in Parkinson's disease
- (2019) Sara Petrillo et al. MOVEMENT DISORDERS
- Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson’s disease
- (2019) Paraskevi Krashia et al. Nature Communications
- Epstein–Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies
- (2019) Amit Bar-Or et al. TRENDS IN MOLECULAR MEDICINE
- Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System?
- (2019) Marc Desforges et al. Viruses-Basel
- Virological and Immunological Outcomes of Coinfections
- (2018) Naveen Kumar et al. CLINICAL MICROBIOLOGY REVIEWS
- The olfactory bulb as the entry site for prion-like propagation in neurodegenerative diseases
- (2018) Nolwen L. Rey et al. NEUROBIOLOGY OF DISEASE
- Flow cytometry analysis of T-cell subsets in cerebrospinal fluid of narcolepsy type 1 patients with long-lasting disease
- (2018) Monica Moresco et al. SLEEP MEDICINE
- Incidence of narcolepsy after H1N1 influenza and vaccinations: Systematic review and meta-analysis
- (2018) Tomi O. Sarkanen et al. SLEEP MEDICINE REVIEWS
- Cerebrospinal fluid biomarker for Parkinson's disease: An overview
- (2018) Fabian Maass et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- CSF α-synuclein inversely correlates with non-motor symptoms in a cohort of PD patients
- (2018) Tommaso Schirinzi et al. PARKINSONISM & RELATED DISORDERS
- How does parkinson's disease begin? Perspectives on neuroanatomical pathways, prions, and histology
- (2017) Per Borghammer MOVEMENT DISORDERS
- Early synaptic dysfunction in Parkinson's disease: Insights from animal models
- (2016) Tommaso Schirinzi et al. MOVEMENT DISORDERS
- Beta-amyloid and phosphorylated tau metabolism changes in narcolepsy over time
- (2016) Claudio Liguori et al. Sleep and Breathing
- Aberrations in Peripheral Inflammatory Cytokine Levels in Parkinson Disease
- (2016) Xiao-Yan Qin et al. JAMA Neurology
- Cerebrospinal fluid cytokine levels in type 1 narcolepsy patients very close to onset
- (2015) Birgitte Rahbek Kornum et al. BRAIN BEHAVIOR AND IMMUNITY
- Immunohistochemical screening for antibodies in recent onset type 1 narcolepsy and after H1N1 vaccination
- (2015) Astrid van der Heide et al. JOURNAL OF NEUROIMMUNOLOGY
- Parkinson's disease
- (2015) Lorraine V Kalia et al. LANCET
- Cerebrospinal fluid and serum cytokine profiles in narcolepsy with cataplexy: A case-control study
- (2014) Yves Dauvilliers et al. BRAIN BEHAVIOR AND IMMUNITY
- CSF beta-amyloid levels are altered in narcolepsy: a link with the inflammatory hypothesis?
- (2014) Claudio Liguori et al. JOURNAL OF SLEEP RESEARCH
- Increased blood-cerebrospinal fluid transfer of albumin in advanced Parkinson’s disease
- (2012) Valerio Pisani et al. Journal of Neuroinflammation
- The Stressful Life Events and Parkinson's Disease: A Case-Control Study
- (2012) Hristina Vlajinac et al. STRESS AND HEALTH
- Post H1N1 vaccination narcolepsy–cataplexy with decreased CSF beta-amyloid
- (2011) Ulf Kallweit et al. SLEEP MEDICINE
- An Updated Meta-Analysis of Risk of Multiple Sclerosis following Infectious Mononucleosis
- (2010) Adam E. Handel et al. PLoS One
- Olfactory dysfunction in narcolepsy with cataplexy
- (2010) Sophie Bayard et al. SLEEP MEDICINE
- A decade of hypocretin/orexin: Accomplishments in sleep medicine
- (2008) Thomas Chacko Thannickal SLEEP MEDICINE REVIEWS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started